CD56+CD16− NK cells from peripheral blood of patients with non-small cell lung cancer (NSCLC), especially squamous cell carcinoma (SCC) subtype, produce higher levels of VEGF, IL-8, and PlGF than those from healthy donors (100). This evidence concerns the gene NCAM1 and non-small cell lung carcinoma.